ENTEKNO ENDUSTRIYEL TEKNOLOJIK VE NANO MALZEMELER SANAYI VE TICARET ANONIM SIRKETI

Their core work

ENTEKNO is a Turkish nanotechnology SME specializing in the development of mineral-based nanomaterials for personal care applications, particularly UV-filtering sunscreen ingredients. Their core work centers on engineering mineral compounds — likely zinc oxide or titanium dioxide — at the nanoscale to be simultaneously safe, transparent on skin, and effective at blocking UV radiation. They brought a proprietary sunscreen ingredient technology through the full EU SME Instrument pathway, from feasibility study to commercial development. Their expertise sits at the intersection of advanced materials engineering and cosmetics ingredient formulation.

What they specialise in

How they've shifted over time

ENTEKNO's H2020 participation is a single, focused technology development arc rather than a diversifying research portfolio. In 2016–2017 they validated the commercial feasibility of their mineral sunscreen nano-ingredient via SME-1; by 2018–2019 they had moved into full product development under SME-2. There is no keyword data to trace a conceptual shift, but the funding progression itself — from €50K feasibility to €544K development — signals deepening commitment to one specific technology rather than broadening scope. Their trajectory is that of a company commercializing a single proprietary innovation, not an R&D house exploring adjacent fields.

ENTEKNO appears to be a single-product technology company betting on one nano-ingredient technology; future collaborations would likely involve scaling production, entering EU cosmetics markets, or extending their mineral nanomaterial platform into adjacent UV-protection or coatings applications.

How they like to work

ENTEKNO operates as an independent technology developer, not a consortium builder. Both their H2020 projects were run solo under the SME Instrument, which requires no consortium partners — meaning they have no documented collaborative history within EU-funded research. This suggests they are most comfortable as a self-directed innovator rather than a consortium participant, and any future partnership would likely involve them as a technology supplier or licensing partner rather than a project coordinator within a multi-partner structure.

ENTEKNO has no documented consortium partners from their H2020 activity — both projects were sole-applicant SME Instrument grants, which by design do not require partners. Their collaborative network within EU-funded research is effectively zero at this stage.

What sets them apart

ENTEKNO occupies a narrow but commercially valuable niche: a Turkish SME that has validated and developed a proprietary mineral-based nano-ingredient for sunscreens through the rigorous EU SME Instrument process, including the highly competitive Phase 2. For a consortium or company seeking a specialized nano-ingredient supplier with EU-funded proof-of-concept behind their technology, ENTEKNO brings a commercially focused product rather than academic research. Their Turkish base also makes them an interesting partner for Horizon Europe projects seeking geographic diversity beyond the EU core.

Highlights from their portfolio

• STAR (SME-2)
  At €544,250 this was the full commercial development phase of their mineral sunscreen technology — securing SME Phase 2 funding is highly competitive and validates both the technical merit and market potential of the nano-ingredient.
• STAR (SME-1)
  The Phase 1 feasibility grant (€50,000) that preceded and unlocked the much larger Phase 2, demonstrating a deliberate and successful strategy of using the EU SME Instrument as a structured commercialization pathway.